Regeneron Pharmaceuticals, Inc.
Maytansinoid derivatives, conjugates thereof, and methods of use

Last updated:

Abstract:

Provided herein are maytansinoid compounds, derivatives thereof, conjugates thereof, and methods of treating or preventing proliferative diseases with the same.

Status:
Grant
Type:

Utility

Filling date:

24 Oct 2019

Issue date:

20 Sep 2022